: National Heart, Lung, and Blood Institute | FDA drug safety communication: Important safety label changes to cholesterol-lowering statins drugs |
---|---|
Hyperlipidemia: Lifestyle measures for prevention of coronary artery disease adult | American Association for Clinical Chemistry |
Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.
17Natural medicines in the clinical management of hyperlipidemia | |
---|---|
: Mayo Foundation for Medical Education and Research; 2018 | : Mayo Foundation for Medical Education and Research; 2018 |
National Center for Complementary and Integrative Health.
28